Laura Moretti

1.3k total citations
28 papers, 662 citations indexed

About

Laura Moretti is a scholar working on Molecular Biology, Virology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura Moretti has authored 28 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Virology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura Moretti's work include HIV Research and Treatment (6 papers), Cell death mechanisms and regulation (5 papers) and Mitochondrial Function and Pathology (4 papers). Laura Moretti is often cited by papers focused on HIV Research and Treatment (6 papers), Cell death mechanisms and regulation (5 papers) and Mitochondrial Function and Pathology (4 papers). Laura Moretti collaborates with scholars based in Italy, United Kingdom and United States. Laura Moretti's co-authors include Andrea Cossarizza, Marcello Pinti, Leonarda Troiano, Stefano Salvioli, María García‐Fernández, Jurek Dobrucki, Milena Nasi, Claudio Franceschi, Claudio Franceschi and Massimiliano Bonafè and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Laura Moretti

25 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Moretti Italy	13	313	116	96	82	78	28	662
Haiying Li China	14	193 0.6×	153 1.3×	402 4.2×	64 0.8×	19 0.2×	40	785
Ove Berglund Sweden	18	510 1.6×	100 0.9×	22 0.2×	125 1.5×	23 0.3×	42	877
Jennifer Chu United States	19	588 1.9×	32 0.3×	63 0.7×	114 1.4×	13 0.2×	40	923
Yasemin Saygıdeğer Türkiye	14	203 0.6×	50 0.4×	32 0.3×	55 0.7×	7 0.1×	37	490
Aaron R. Goldman United States	18	659 2.1×	39 0.3×	115 1.2×	165 2.0×	18 0.2×	38	1.0k
June M. Lull United States	7	279 0.9×	117 1.0×	12 0.1×	125 1.5×	12 0.2×	10	506
Michael Weinberger United Kingdom	13	346 1.1×	65 0.6×	51 0.5×	54 0.7×	3 0.0×	19	598
David V. Weinberg United States	28	354 1.1×	113 1.0×	15 0.2×	60 0.7×	17 0.2×	66	2.1k
Corinne Lionne France	18	602 1.9×	42 0.4×	16 0.2×	101 1.2×	5 0.1×	59	969
Lynne Rainen United States	11	350 1.1×	35 0.3×	46 0.5×	57 0.7×	4 0.1×	14	659

Countries citing papers authored by Laura Moretti

Since Specialization

Citations

This map shows the geographic impact of Laura Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Moretti more than expected).

Fields of papers citing papers by Laura Moretti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Moretti. The network helps show where Laura Moretti may publish in the future.

Co-authorship network of co-authors of Laura Moretti

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Moretti. A scholar is included among the top collaborators of Laura Moretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Moretti. Laura Moretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moretti, Laura, Marta Laganà, Marco Ravanelli, et al.. (2026). Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Research and Treatment. 215(2). 58–58.

Gemelli, Maria, Diego Cortinovis, Giulia Carola, et al.. (2025). Efficacy of immune checkpoint inhibitors (ICIs) in PD-L1 negative Non-Small Cell Lung Cancer (NSCLC) – A meta-analysis based on reconstructed individual participant data. Lung Cancer. 205. 108621–108621. 3 indexed citations

Banerjee, Susana, Alexandra Taylor, Judith M. Bliss, et al.. (2024). 798TiP Stereotactic radiotherapy alone or followed by niraparib for oligometastases or oligoprogression in ovarian cancer following PARP inhibitor therapy: SOPRANO trial. Annals of Oncology. 35. S594–S595. 1 indexed citations

Moretti, Laura, Deborah Cosentini, Salvatore Grisanti, et al.. (2024). Adjuvant denosumab for early breast cancer–Evidence and controversy. The Breast. 78. 103826–103826.

Kingston, Belinda, Alex Pearson, María Teresa Herrera-Abreu, et al.. (2023). ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1 -Mutant Breast Cancer. Cancer Discovery. 14(2). 274–289. 21 indexed citations

Silvestri, Evelina, Francesca Servadei, Ione Tamagnini, Laura Moretti, & Maria Paola Bonasoni. (2023). Discordant Eosinophilic/T-Cell Chorionic Vasculitis in a Dichorionic Diamniotic Placenta. International Journal of Molecular Sciences. 24(11). 9207–9207.

Holtzman, Bryan, et al.. (2021). Specific dietary practices in female athletes and their association with positive screening for disordered eating. Journal of Eating Disorders. 9(1). 50–50. 16 indexed citations

Bhattacharya, Indrani, Laura Moretti, Joanne Haviland, et al.. (2018). Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies. Research Involvement and Engagement. 4(1). 22–22. 5 indexed citations

Turner, Nicholas C., Hannah Bye, Sarah Kernaghan, et al.. (2018). Abstract OT1-06-03: The plasmaMATCH trial: A multiple parallel cohort, open-label, multi-centre phase II clinical trial of ctDNA screening to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010). Cancer Research. 78(4_Supplement). OT1–6. 7 indexed citations

10.

Salvioli, Stefano, Gianluca Storci, Marcello Pinti, et al.. (2003). Apoptosis-resistant phenotype in HL-60-derived cells HCW-2 is related to changes in expression of stress-induced proteins that impact on redox status and mitochondrial metabolism. Cell Death and Differentiation. 10(2). 163–174. 23 indexed citations

11.

Pinti, Marcello, Leonarda Troiano, Milena Nasi, et al.. (2002). Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death and Differentiation. 9(4). 431–438. 43 indexed citations

12.

Mussini, Cristina, Marcello Pinti, Vanni Borghi, et al.. (2002). Features of ‘CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy. AIDS. 16(12). 1609–1616. 46 indexed citations

13.

Nasi, Milena, Marcello Pinti, Leonarda Troiano, et al.. (2002). The evolution of cell killing: when a target cell became “invited” to choose how to die.. IRIS UNIMORE (University of Modena and Reggio Emilia). 343. 82–89. 2 indexed citations

14.

Viganò, M, Marcello Pinti, Milena Nasi, et al.. (2001). Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: The role of age. Journal of Allergy and Clinical Immunology. 108(3). 439–445. 12 indexed citations

15.

García‐Fernández, María, Leonarda Troiano, Laura Moretti, et al.. (2000). Changes in intramitochondrial cardiolipin distribution in apoptosis‐resistant HCW‐2 cells, derived from the human promyelocytic leukemia HL‐60. FEBS Letters. 478(3). 290–294. 31 indexed citations

16.

Pinti, Marcello, Milena Nasi, Laura Moretti, et al.. (2000). Quantitation of CD95 and CD95L mRNA Expression in Chronic and Acute HIV‐1 Infection by Competitive RT‐PCR. Annals of the New York Academy of Sciences. 926(1). 46–51. 6 indexed citations

17.

Salvioli, Stefano, Jurek Dobrucki, Laura Moretti, et al.. (2000). Mitochondrial heterogeneity during staurosporine-induced apoptosis in HL60 cells: Analysis at the single cell and single organelle level. Cytometry. 40(3). 189–197. 70 indexed citations

18.

Monti, Daniela, Laura Moretti, Stefano Salvioli, et al.. (2000). C60 Carboxyfullerene Exerts a Protective Activity against Oxidative Stress-Induced Apoptosis in Human Peripheral Blood Mononuclear Cells. Biochemical and Biophysical Research Communications. 277(3). 711–717. 80 indexed citations

19.

Salvioli, Stefano, Cristiana Barbi, Jurek Dobrucki, et al.. (2000). Opposite role of changes in mitochondrial membrane potential in different apoptotic processes. FEBS Letters. 469(2-3). 186–190. 41 indexed citations

20.

Cossarizza, Andrea, Cristina Mussini, Vanni Borghi, et al.. (1999). Apoptotic Features of Peripheral Blood Granulocytes and Monocytes during Primary, Acute HIV Infection. Experimental Cell Research. 247(1). 304–311. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact